About the Company
We do not have any company description for CNS Pharmaceuticals, Inc. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $CNSP News
CNS Pharmaceuticals to Present at the LSX World Congress 2024
HOUSTON, TX / ACCESSWIRE / April 23, 2024 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP)("CNS" or the "Company"), a ...
Tinygemsbreaks CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO To Present At LSX World Congress 2024
CNS Pharmaceuticals (NASDAQ: CNSP) , a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic canc ...
CNS Pharmaceuticals Reports Full Year 2023 Financial Results and Highlights Recent Corporate and Clinical Achievements
About CNS Pharmaceuticals, Inc.CNS Pharmaceuticals is a clinical-stage pharmaceutical company developing a pipeline of anti-cancer drug candidates for the treatment of primary and metastatic ...
Biomednewsbreaks CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Spotlighted In Upcoming Virtual Investor Lunch Break Event
CNS Pharmaceuticals (NASDAQ: CNSP) , a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic canc ...
CNS Pharmaceuticals Inc.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
CNS Pharmaceuticals (NASDAQ: CNSP) CEO to Present at LSX World Congress 2024
Detailed price information for Cns Pharmaceuticals Inc (CNSP-Q) from The Globe and Mail including charting and trades.
CNS Pharmaceuticals to Present at the LSX World Congress 2024
HOUSTON, TX / ACCESSWIRE / April 23, 2024 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for ...
CNS Pharmaceuticals, Inc.: CNS Pharmaceuticals to Present at the LSX World Congress 2024
HOUSTON, TX / ACCESSWIRE / April 23, 2024 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing ...
Loading the latest forecasts...